Pmv Pharmaceuticals Inc (PMVP) — Financial Flexibility Index
Pmv Pharmaceuticals Inc (PMVP) has a Financial Flexibility Index of -1.38x as of June 2026. Free cash flow of $-14.58 Million (operating CF $-14.58 Million minus capex $0.00) represents -1% of total liabilities ($10.57 Million). Check Pmv Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pmv Pharmaceuticals Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Pmv Pharmaceuticals Inc across 8 annual periods. For the full cash flow conversion analysis, see Pmv Pharmaceuticals Inc (PMVP) cash conversion ratio.
Annual Financial Flexibility Index for Pmv Pharmaceuticals Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Pmv Pharmaceuticals Inc. Explore Pmv Pharmaceuticals Inc (PMVP) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.21x | $-73.55 Million | $-73.58 Million | $11.85 Million | ▼ -86.4% |
| 2024 | -3.33x | $-50.63 Million | $-51.28 Million | $15.21 Million | ▼ -61.1% |
| 2023 | -2.07x | $-54.70 Million | $-55.66 Million | $26.46 Million | ▲ +10.0% |
| 2022 | -2.30x | $-55.78 Million | $-63.76 Million | $24.28 Million | ▼ -16.9% |
| 2021 | -1.97x | $-45.22 Million | $-46.57 Million | $23.01 Million | ▲ +61.3% |
| 2020 | -5.08x | $-32.59 Million | $-32.74 Million | $6.41 Million | ▼ -3917.9% |
| 2019 | -0.13x | $-21.96 Million | $-22.07 Million | $173.51 Million | ▲ +5.8% |
| 2018 | -0.13x | $-14.73 Million | $-15.18 Million | $109.60 Million | — |